What is AgaMatrix?
AgaMatrix specializes in the development, manufacturing, and marketing of advanced diagnostic technologies for blood glucose monitoring. Their product suite is designed to manage glucose data effectively through mobile and cloud-based platforms, aiming to improve patient outcomes and healthcare management. The company's commitment to innovation in diabetes care positions it as a key player in the health technology landscape.
How much funding has AgaMatrix raised?
AgaMatrix has raised a total of $63.7M across 5 funding rounds:
Series A
$2.7M
Series B
$5M
Series C
$23.7M
Debt
$32M
Debt
$350K
Series A (2003): $2.7M with participation from Tank Partners and Collaborative Fund
Series B (2007): $5M, investors not publicly disclosed
Series C (2008): $23.7M supported by Noble International Ltd
Debt (2017): $32M featuring Prospect Capital Corporation
Debt (2020): $350K backed by PPP
Key Investors in AgaMatrix
Prospect Capital Corporation
Prospect Capital Corporation is a private equity firm that provides financing for middle market companies. Their investment in AgaMatrix suggests a focus on established companies with strong market potential in the technology or healthcare sectors.
Noble International Ltd
Noble International Ltd, an Aptar Pharma company, is a leader in improving patient adherence through training devices and pharma services. Their involvement indicates a strategic interest in technologies that enhance patient engagement and support for medical devices.
PPP
Public-Private Partnership
What's next for AgaMatrix?
The recent strategic investment in AgaMatrix signals a strong confidence in the company's future growth and its capacity to further innovate within the diabetes management market. This capital infusion is likely to fuel advancements in their diagnostic technologies, expand market reach, and enhance their data management platforms. AgaMatrix is poised to leverage this backing to solidify its position and address the evolving needs of patients and healthcare providers in managing chronic conditions.
See full AgaMatrix company page
